Prime Medicine (PRME) FCF Margin: 2024-2025
Historic FCF Margin for Prime Medicine (PRME) over the last 2 years, with Sep 2025 value amounting to -2,880.49%.
- Prime Medicine's FCF Margin rose 1012860.00% to -2,880.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,925.63%, marking a year-over-year change of. This contributed to the annual value of -4,363.36% for FY2024, which is N/A change from last year.
- Per Prime Medicine's latest filing, its FCF Margin stood at -2,880.49% for Q3 2025, which was up 25.28% from -3,855.07% recorded in Q2 2025.
- Over the past 5 years, Prime Medicine's FCF Margin peaked at 662.12% during Q4 2024, and registered a low of -13,009.09% during Q3 2024.
- In the last 2 years, Prime Medicine's FCF Margin had a median value of -3,690.91% in 2025 and averaged -5,743.14%.
- Data for Prime Medicine's FCF Margin shows a peak YoY soared of 1,012,860bps (in 2025) over the last 5 years.
- Quarterly analysis of 2 years shows Prime Medicine's FCF Margin stood at 662.12% in 2024, then surged by 1,012,860bps to -2,880.49% in 2025.
- Its last three reported values are -2,880.49% in Q3 2025, -3,855.07% for Q2 2025, and -3,526.75% during Q1 2025.